Scancell utilises nanotechnology to amp up solid tumour vaccine 23-May-2019 By Ben Hargreaves Scancell and Cancer Research UK use nanodelivery technology to activate the body’s immune system, boosting its ability to target and destroy cancer cells.
Almac expanding personalized cancer vaccine production facilities 21-Jan-2019 By Melissa Fassbender The Almac Group is doubling its Edinburgh-based footprint to help meet the growing demand for personalized cancer vaccines production.